Evaluation of safety and efficacy of topical 4% nicotinamide in treatment of psoriasis; among a representative sample of Egyptians (an analytical observational study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of safety and efficacy of topical 4% nicotinamide in treatment of psoriasis; among a representative sample of Egyptians (an analytical observational study)

Published:2022-08-03 Issue:9 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

El‐Khalawany Mohamed¹,Nouh Ahmed H.¹^ORCID,Kadah Ahmed S.²^ORCID,Elsheikh Maged³,Said Marwa⁴^ORCID

Affiliation:

1. Department of Dermatology and Venereology, Faculty of Medicine Al Azhar University Cairo Egypt

2. Department of Dermatology and Venereology, Faculty of Medicine, Al‐Hussin University Hospital Al‐Azhar University Cairo Egypt

3. Department of Dermatology and Venereology Military Medical Academy Cairo Egypt

4. Department of Dermatology and Venereology, Faculty of Medicine for Girls Al‐Azhar University Cairo Egypt

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15734

Reference20 articles.

1. Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight

2. World Health Organization Global diffusion of eHealth: making universal health coverage achievable: report of the third global survey on eHealth.World Health Organization;2017.

3. Psoriasis Severity and the Prevalence of Major Medical Comorbidity

4. Scalp psoriasis: European consensus on grading and treatment algorithm;Ortonne J;Wiley Online Library.,2009

5. Risk Factors for the Development of Psoriasis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP